Corcept: 3Q Earnings Snapshot
MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Thursday reported third-quarter profit of $17.8 million.
The Menlo Park, California-based company said it had net income of 14 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, were 22 cents per share.
The drug developer posted revenue of $64.4 million in the period.
Corcept expects full-year revenue in the range of $250 million to $270 million.
Corcept shares have dropped 32 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $12.23, a decrease of 36 percent in the last 12 months.